Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer.

The study evaluated ctDNA detection after curative-intent therapy in early breast cancer using structural variants, noting that detection in this setting is highly prognostic of recurrence.

Clinical Cancer ResearchPubMed 39785866DOI 10.1158/1078-0432.CCR-24-3472